In the Lab
The breakthrough gives an unprecedented look at the varied and shifting poses of a protein in action.
Q&A
An experimental drug for acute myelogenous leukemia might potentially help many more patients than previously thought by controlling epigenetic processes, according to a recent MSK study.
